Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New AI Tool Outperforms Previous Methods for Identifying Colorectal Cancer from Tissue Sample Analysis

By LabMedica International staff writers
Posted on 03 Mar 2025

Tissue analysis typically involves a pathologist reviewing scanned digital slides from a patient’s intestinal sample and marking specific areas, such as those where cancerous and related tissues are present. More...

A new artificial intelligence (AI)-driven tool has now been developed to identify colorectal cancer in tissue samples that surpasses all previous models in terms of classification accuracy.

This tool was the result of a collaborative study led by researchers at the University of Jyväskylä (Jyväskylä, Finland). The AI model created in this study demonstrated superior performance in classifying tissue samples compared to prior models. This new tool has the potential to streamline the process for doctors by automating the analysis of tissue slides. It analyzes samples and highlights areas with various tissue types, offering a level of accuracy that could greatly reduce the workload of histopathologists, leading to faster diagnoses, prognoses, and clinical insights.

The research team has made this AI tool publicly available to promote further research and collaboration. While the results are promising, the team emphasizes that the integration of AI tools into clinical practice should be approached cautiously. For AI solutions to become standard in clinical settings, they must undergo a thorough validation process to ensure that they meet both clinical and regulatory standards.

"Based on our study, the developed model is able to identify all tissue categories relevant for cancer identification, with an accuracy of 96.74%," said Fabi Prezja, the researcher responsible for designing the method. "The free availability aims to accelerate future advances by encouraging scientists, developers and researchers worldwide to continue developing the tool and finding new applications for it."

Related Links:
University of Jyväskylä


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Electrolyte Analyzer
BKE-B
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Three presentations will examine Arima Genomics’ high-throughput Hi-C sequencing technology in salivary gland cancer, triple-negative breast cancer, and aggressive cutaneous T-cell lymphoma (Photo courtesy of Arima Genomics)

New Research Examines Hi-C Sequencing Across Solid Tumors and Lymphoma

Arima Genomics (Carlsbad, CA, USA) will present new research highlighting the expanding clinical applications of its Aventa FusionPlus and Aventa Lymphoma tests at the Association for Molecular Pathology... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: Study design and collection of lower respiratory tract lining fluid (RTLF) using the PExA instrument. (Aguilera K, Hober A, Greilert Norin N, et al. eBioMedicine, 2026. doi:10.1016/j.ebiom.2026.106538)

Exhaled Breath Particles Reveal Virus-Specific Antibodies in the Lower Airways

Respiratory viruses such as influenza virus, SARS-CoV-2, and respiratory syncytial virus (RSV) require immune protection across the airway mucosa. Antibodies in the respiratory tract lining are important... Read more

Microbiology

view channel
Image: The multiplex molecular panels assess 22 and 11 targets, respectively, spanning bacteria, viruses, and parasites from a single stool sample, with results available in approximately one hour (Photo courtesy of bioMérieux)

Molecular Panels Gain FDA Clearance for One-Hour Gastrointestinal Pathogen Testing

Acute infectious gastroenteritis, caused by viral, bacterial, and parasitic pathogens, remains a significant global health concern that inflames the gastrointestinal tract. Symptoms such as diarrhea, vomiting,... Read more

Industry

view channel
Image: Siemens Healthineers has begun carving out its in vitro diagnostics business as a standalone company named Olyrian Diagnostics (Photo courtesy of Siemens Healthineers)

Siemens Healthineers Begins Transition Toward Standalone Olyrian Diagnostics Business

Siemens Healthineers has begun carving out its in vitro diagnostics business, which will operate as Olyrian Diagnostics. The new name will be introduced in stages as the business prepares to become a standalone... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.